GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MRT Inc (TSE:6034) » Definitions » Cyclically Adjusted Price-to-FCF

MRT (TSE:6034) Cyclically Adjusted Price-to-FCF : 7.78 (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is MRT Cyclically Adjusted Price-to-FCF?

As of today (2024-09-22), MRT's current share price is 円860.00. MRT's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 was 円110.56. MRT's Cyclically Adjusted Price-to-FCF for today is 7.78.

The historical rank and industry rank for MRT's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSE:6034' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5.86   Med: 7.91   Max: 9.17
Current: 7.69

During the past years, MRT's highest Cyclically Adjusted Price-to-FCF was 9.17. The lowest was 5.86. And the median was 7.91.

TSE:6034's Cyclically Adjusted Price-to-FCF is ranked better than
79.01% of 181 companies
in the Healthcare Providers & Services industry
Industry Median: 21.56 vs TSE:6034: 7.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MRT's adjusted free cash flow per share data for the three months ended in Jun. 2024 was 円155.401. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is 円110.56 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


MRT Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for MRT's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MRT Cyclically Adjusted Price-to-FCF Chart

MRT Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only - - - - -

MRT Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 8.80 7.46

Competitive Comparison of MRT's Cyclically Adjusted Price-to-FCF

For the Medical Care Facilities subindustry, MRT's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MRT's Cyclically Adjusted Price-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MRT's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MRT's Cyclically Adjusted Price-to-FCF falls into.



MRT Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

MRT's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=860.00/110.56
=7.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MRT's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, MRT's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=155.401/108.2000*108.2000
=155.401

Current CPI (Jun. 2024) = 108.2000.

MRT Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201409 0.000 98.500 0.000
201412 0.000 97.900 0.000
201503 0.000 97.900 0.000
201506 0.000 98.400 0.000
201509 0.000 98.500 0.000
201512 0.000 98.100 0.000
201603 0.000 97.900 0.000
201606 -9.736 98.100 -10.738
201609 10.912 98.000 12.048
201612 5.620 98.400 6.180
201703 -5.459 98.100 -6.021
201706 13.102 98.500 14.392
201709 3.863 98.800 4.231
201712 5.134 99.400 5.589
201803 -8.793 99.200 -9.591
201806 5.721 99.200 6.240
201809 -1.503 99.900 -1.628
201812 5.558 99.700 6.032
201903 -4.465 99.700 -4.846
201906 -4.280 99.800 -4.640
201909 17.892 100.100 19.340
201912 22.065 100.500 23.756
202003 -16.610 100.300 -17.918
202006 28.441 99.900 30.804
202009 0.984 99.900 1.066
202012 20.151 99.300 21.957
202103 -20.016 99.900 -21.679
202106 1.678 99.500 1.825
202109 -162.932 100.100 -176.116
202112 108.487 100.100 117.266
202203 224.454 101.100 240.217
202206 347.397 101.800 369.237
202209 157.194 103.100 164.970
202212 65.369 104.100 67.944
202303 -65.431 104.400 -67.813
202306 75.494 105.200 77.647
202309 -72.340 106.200 -73.702
202312 11.439 106.800 11.589
202403 -50.467 107.200 -50.938
202406 155.401 108.200 155.401

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


MRT  (TSE:6034) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


MRT Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of MRT's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


MRT Business Description

Traded in Other Exchanges
N/A
Address
1-18-2 Kanan, 3rd Floor, Frame Kananzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through Internet. It provides part-time and full-time physician referral services through physician referral site MedRT.com; as well as part-time job referral; job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.

MRT Headlines

No Headlines